Cargando…
Multifractal foundations of biomarker discovery for heart disease and stroke
Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-pos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600152/ https://www.ncbi.nlm.nih.gov/pubmed/37880302 http://dx.doi.org/10.1038/s41598-023-45184-2 |
_version_ | 1785125926688784384 |
---|---|
author | Mangalam, Madhur Sadri, Arash Hayano, Junichiro Watanabe, Eiichi Kiyono, Ken Kelty-Stephen, Damian G. |
author_facet | Mangalam, Madhur Sadri, Arash Hayano, Junichiro Watanabe, Eiichi Kiyono, Ken Kelty-Stephen, Damian G. |
author_sort | Mangalam, Madhur |
collection | PubMed |
description | Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-positive and false-negative rates. The application of standard cut-off points and risk scores across populations hinges upon the assumption of such generalizability. Such generalizability, in turn, hinges upon this condition that the phenomenon investigated by current statistical methods is ergodic, i.e., its statistical measures converge over individuals and time within the finite limit of observations. However, emerging evidence indicates that biological processes abound with nonergodicity, threatening this generalizability. Here, we present a solution for how to make generalizable inferences by deriving ergodic descriptions of nonergodic phenomena. For this aim, we proposed capturing the origin of ergodicity-breaking in many biological processes: cascade dynamics. To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and decades of research, lacks reliable biomarkers and risk stratification tools. We showed that raw R-R interval data and its common descriptors based on mean and variance are nonergodic and non-specific. On the other hand, the cascade-dynamical descriptors, the Hurst exponent encoding linear temporal correlations, and multifractal nonlinearity encoding nonlinear interactions across scales described the nonergodic heart rate variability more ergodically and were specific. This study inaugurates applying the critical concept of ergodicity in discovering and applying digital biomarkers of health and disease. |
format | Online Article Text |
id | pubmed-10600152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106001522023-10-27 Multifractal foundations of biomarker discovery for heart disease and stroke Mangalam, Madhur Sadri, Arash Hayano, Junichiro Watanabe, Eiichi Kiyono, Ken Kelty-Stephen, Damian G. Sci Rep Article Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-positive and false-negative rates. The application of standard cut-off points and risk scores across populations hinges upon the assumption of such generalizability. Such generalizability, in turn, hinges upon this condition that the phenomenon investigated by current statistical methods is ergodic, i.e., its statistical measures converge over individuals and time within the finite limit of observations. However, emerging evidence indicates that biological processes abound with nonergodicity, threatening this generalizability. Here, we present a solution for how to make generalizable inferences by deriving ergodic descriptions of nonergodic phenomena. For this aim, we proposed capturing the origin of ergodicity-breaking in many biological processes: cascade dynamics. To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and decades of research, lacks reliable biomarkers and risk stratification tools. We showed that raw R-R interval data and its common descriptors based on mean and variance are nonergodic and non-specific. On the other hand, the cascade-dynamical descriptors, the Hurst exponent encoding linear temporal correlations, and multifractal nonlinearity encoding nonlinear interactions across scales described the nonergodic heart rate variability more ergodically and were specific. This study inaugurates applying the critical concept of ergodicity in discovering and applying digital biomarkers of health and disease. Nature Publishing Group UK 2023-10-25 /pmc/articles/PMC10600152/ /pubmed/37880302 http://dx.doi.org/10.1038/s41598-023-45184-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Mangalam, Madhur Sadri, Arash Hayano, Junichiro Watanabe, Eiichi Kiyono, Ken Kelty-Stephen, Damian G. Multifractal foundations of biomarker discovery for heart disease and stroke |
title | Multifractal foundations of biomarker discovery for heart disease and stroke |
title_full | Multifractal foundations of biomarker discovery for heart disease and stroke |
title_fullStr | Multifractal foundations of biomarker discovery for heart disease and stroke |
title_full_unstemmed | Multifractal foundations of biomarker discovery for heart disease and stroke |
title_short | Multifractal foundations of biomarker discovery for heart disease and stroke |
title_sort | multifractal foundations of biomarker discovery for heart disease and stroke |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600152/ https://www.ncbi.nlm.nih.gov/pubmed/37880302 http://dx.doi.org/10.1038/s41598-023-45184-2 |
work_keys_str_mv | AT mangalammadhur multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke AT sadriarash multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke AT hayanojunichiro multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke AT watanabeeiichi multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke AT kiyonoken multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke AT keltystephendamiang multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke |